📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
TeamLease Receives ₹52.76 Cr GST Show Cause Notice for FY23
TeamLease Services received a Show Cause Notice from the Karnataka Commercial Taxes Department demanding ₹52.76 crore for FY 2022-23 under Section 73(1) of the KGST/CGST Act. The total claim consists of ₹28.92 crore in tax, ₹20.95 crore in interest, and ₹2.89 crore in penalties, primarily concerning turnover adjustments and exempt supplies reconciliation. Relative to the company's financials, the ₹52.76 crore demand represents ~35% of FY26 TTM PAT (₹150 crore) and ~5.5% of net worth. The company noted that out of nine original issues, seven were dropped, and it plans to submit its formal reply (DRC-06) by October 29, 2026.
Confidence: HIGH
What changedTeamLease received a formal GST Show Cause Notice from Karnataka tax authorities proposing a ₹52.76 crore liability for FY 2022-23.
Why it mattersWhile TeamLease generated ₹11,982 crore in TTM revenue, thin operating margins (1.3%) mean the ₹52.76 crore exposure represents approximately 35% of its annual net profit (₹150 crore TTM PAT).
Total Demand Amount: INR 52,76,08,537Proposed Tax Component: INR 28,91,89,566Demand vs TTM PAT: ~35.2%Alleged Tax Overstatement Claimed by Co: INR 3,26,83,376Reply Due Date: October 29, 2026
📅 Short termThe company intends to contest the notice by October 29, 2026, highlighting computational overstatements of ₹3.27 crore in tax rates.
📈 Long termIf sustained upon final adjudication, the liability could dent cash flows and require provisions given the company's lean profit margins, though tax disputes often face prolonged appellate proceedings.
⚠ Risk flags
- Notice amount equals ~35% of TTM PAT
- 13-day delay in disclosure cited as an internal communication gap between tax and secretarial teams
Key Highlights
Total financial implication demanded is INR 52,76,08,537, including tax, interest, and penalties
Proposed tax component is INR 28,91,89,566, with interest of INR 20,95,00,014 and penalty of INR 2,89,18,957
Notice covers FY 2022-23 (April 2022 to March 2023) under Section 73(1) of KGST and CGST Act
7 out of 9 initial issues raised under Form GST DRC-01A have already been dropped by authorities
Company must file its reply in Form GST DRC-06 on or before October 29, 2026
👀 What to Watch
Track the filing of the company's reply in Form GST DRC-06 by October 29, 2026, and any subsequent adjudication order from the GST department.
Shalibhadra Finance Approves ₹24 Cr Secured NCD Issuance via Private Placement
The Board of Directors of Shalibhadra Finance Limited has approved the issuance of senior, secured, rated, listed, redeemable, transferable Non-Convertible Debentures (NCDs) aggregating up to ₹24 crore on a private placement basis. The debentures are proposed to be listed on the BSE Limited. The fundraise of ₹24 crore is material for the NBFC, representing ~55.8% of its TTM revenue of ₹43 crore and ~10.2% of its current market capitalization of ₹235 crore. Specific terms such as coupon rate, allotment date, and maturity date will be finalized in subsequent transaction documents.
Confidence: HIGH
What changedThe Board approved a fresh debt fundraise of up to ₹24 crore through secured, listed NCDs.
Why it mattersThe capital will support lending asset growth for this small NBFC; the issue represents roughly 56% of TTM revenue and over 10% of market capitalization.
Issue Size: Up to INR 24,00,00,000/-Issue size vs TTM revenue: ~55.8%Issue size vs Market Cap: ~10.2%
📅 Short termSentimentally positive as it provides liquidity for business operations; near-term focus will be on borrowing cost and investor participation.
📈 Long termHelps scale up the AUM and interest income base, provided the cost of debt is well below the portfolio lending yield.
⚠ Risk flags
- Interest rate risk / borrowing cost not yet disclosed
- Execution and asset quality risk associated with expanding the credit book
Key Highlights
Approved issue size of up to ₹24,00,00,000 via NCDs on a private placement basis
Instrument structure: Senior, secured, rated, listed, redeemable, transferable debentures
Debentures are proposed to be listed on BSE Limited
Coupon rate, tenure, and allotment dates to be determined in final transaction documents
👀 What to Watch
Track subsequent filings for the finalization of the coupon rate, tenure, credit rating details, and actual deployment of funds toward loan book expansion.
NCLT Dismisses ₹64.92 Cr IBC Insolvency Plea Against FirstCry Subsidiary Globalbees
The Hon'ble NCLT New Delhi Bench has dismissed an insolvency application filed under Section 7 of the IBC against Globalbees Brands Private Limited, a material subsidiary of Brainbees Solutions (FirstCry). The joint application, originally filed by Ashutosh Garg, Paritosh Garg, and Manju Agarwal, had claimed an alleged default of ₹64.92 crore plus 18% annual interest from May 9, 2025. With NCLT rejecting the application via its order pronounced on October 9, 2026, the overhang of corporate insolvency resolution proceedings (CIRP) against Globalbees is removed.
Confidence: HIGH
What changedThe NCLT dismissed the ₹64.92 crore Section 7 insolvency petition filed against material subsidiary Globalbees Brands.
Why it mattersClears a major legal dispute and eliminates the risk of subsidiary insolvency or resolution proceedings, protecting FirstCry's consolidated brand portfolio.
Alleged claim dismissed: INR 64,92,38,997/-Claimed interest rate: 18% p.a.Claim interest start date: May 9, 2025Order pronounced date: October 09, 2026Claim vs Net Worth: ~1.02%
📅 Short termRemoves legal uncertainty around Globalbees, likely seen as a positive development following previous stock declines.
📈 Long termLimited operational impact, but removes an overhang allowing management to focus on brand rationalization and profitability in Globalbees.
⚠ Risk flags
- Potential appeal by claimants before NCLAT
Key Highlights
NCLT rejected the Section 7 IBC application against material subsidiary Globalbees Brands Private Limited on October 9, 2026.
The dismissed claim amount was ₹64,92,38,997 (₹64.92 crore) along with 18% p.a. interest claimed from May 9, 2025.
The disputed amount represents ~0.76% of FirstCry's TTM revenue of ₹8,549 crore and ~1.02% of net worth (₹6,347 crore).
👀 What to Watch
Track whether the applicants appeal the NCLT rejection before the National Company Law Appellate Tribunal (NCLAT).
Texmo Pipes Faces ₹25.66 Cr Adverse Arbitral Award in Larsen & Toubro Dispute
Texmo Pipes and Products announced that an arbitral tribunal has passed an award directing the company to pay ₹25.66 crore plus 8% annual interest and costs to Larsen and Toubro Limited. The arbitrator also dismissed Texmo's counter-claims of ₹23.51 crore as being outside the arbitration agreement's purview, though permitting separate legal challenges. The awarded amount represents ~171% of Texmo's TTM net profit of ₹15 crore and ~17.6% of its market capitalization (₹146 crore), posing a substantial financial liability if enforced. Texmo stated it does not foresee operational disruption and is evaluating legal recourse to challenge the award.
Confidence: HIGH
What changedA sole arbitrator passed an adverse award ordering Texmo Pipes to pay ₹25.66 crore plus 8% interest and costs to L&T, while dismissing Texmo's ₹23.51 crore counter-claim.
Why it mattersThe ₹25.66 crore liability exceeds Texmo's entire annual net profit (₹13.92 crore in FY26) and equals ~11.4% of net worth, creating significant cash flow risk if enforced.
Award amount against company: Rs. 25.66 cr.Interest rate awarded: eight percent per annumDismissed counter-claim: Rs. 23.51 cr.Award vs TTM PAT: ~171%Award vs Market Cap: ~17.6%
📅 Short termNegative sentiment likely as market factors in the potential cash outflow or provisioning requirements; company plans legal challenges to contest the award.
📈 Long termIf upheld upon appeal, the payment could stretch Texmo's balance sheet, deplete cash reserves, or increase leverage, impacting financial flexibility.
⚠ Risk flags
- Adverse legal award exceeding full-year earnings
- Cash outflow risk with 8% p.a. interest compounding until settlement
- Dismissal of ₹23.51 cr counter-claim limits immediate netting off
Key Highlights
Arbitral award directs payment of ₹25.66 cr to Larsen & Toubro Limited
Interest awarded on the claim amount at 8% per annum plus legal costs
Company's counter-claim of ₹23.51 cr dismissed as outside arbitration scope
Award passed on September 24, 2026, and reviewed by Board on October 13, 2026
👀 What to Watch
Track whether the company files a petition under Section 34 of the Arbitration and Conciliation Act to stay/challenge the award, and monitor upcoming quarterly results for potential legal provisions or contingent liability disclosures.
CARE Assigns 'CARE A+; Stable' Rating to 7 O2 Renewable Energy Subsidiaries
JSW Energy Limited announced that CARE Ratings assigned a 'CARE A+; Stable' credit rating to the long-term bank facilities of 7 step-down subsidiaries under the O2 Renewable Energy platform. The rated entities include O2 Renewable Energy IV, VI, X, XIII, XIV, XXII, and XXIII Private Limited. These ratings follow JSW Energy's strategic M&A acquisitions in renewable assets to scale operational capacity toward its 30 GW target by 2030. The standalone amounts for the bank facilities were not disclosed in the regulatory filing.
Confidence: HIGH
What changedCARE Ratings assigned formal long-term bank facility ratings of 'CARE A+; Stable' across 7 O2 Renewable Energy step-down subsidiaries.
Why it mattersA healthy credit rating of 'CARE A+' aids in securing competitive interest rates and refinancing terms for renewable project debt, supporting the company's leveraged expansion (Debt of ₹14,959 Cr).
Number of subsidiaries rated: 7Assigned rating: CARE A+; StableTotal Company Debt: Rs 14959 Cr
📅 Short termNeutral to mildly positive sentiment as credit profile validation aids debt servicing and financing clarity for recent asset additions.
📈 Long termStable investment-grade ratings facilitate cost-effective capital access essential for reaching JSW Energy's 30 GW by 2030 target.
⚠ Risk flags
- Counterparty payment delays from state DISCOMs
- Interest rate sensitivity across high consolidated debt levels
Key Highlights
CARE Ratings assigned 'CARE A+; Stable' ratings via releases dated October 12, 2026
Covers long-term bank facilities of 7 step-down subsidiaries in the O2 Renewable Energy portfolio
Subsidiaries rated: O2 Renewable Energy IV, VI, X, XIII, XIV, XXII, and XXIII Private Limited
Supports JSW Energy's aggressive expansion strategy across its 13.2 GW power portfolio
👀 What to Watch
Monitor upcoming quarterly disclosures to assess borrowing costs and debt integration details associated with the acquired O2 Power platforms.
Vishnusurya Projects Approves Migration from NSE Emerge to NSE Main Board
The Board of Directors of Vishnusurya Projects and Infra Limited has approved the migration of its equity shares from the NSE Emerge SME platform to the Main Board of the NSE. The move is subject to shareholder approval via a postal ballot through remote e-voting, as well as approvals from NSE and relevant regulatory authorities. M/s. BP & Associates has been appointed as the Scrutinizer and CDSL as the remote e-voting agency. With a market capitalization of ₹336 Cr and TTM revenue of ₹352 Cr, migrating to the Main Board typically increases stock liquidity and broadens institutional investor participation.
Confidence: HIGH
What changedThe company's Board has formally initiated the process to shift share listings from the SME platform (NSE Emerge) to the NSE Main Board.
Why it mattersGraduating to the Main Board removes the SME trading lot-size constraints, improving trading liquidity and opening access to institutional and broader retail investors.
Market Capitalization: Rs 336 CrTTM Revenue: Rs 352 CrBoard meeting start time: 5:30 P.M. (IST)Board meeting conclusion time: 5:43 p.m. (IST)
📅 Short termShareholders will vote on the special resolution via postal ballot; sentiment generally leans positive for SME companies seeking mainboard listing.
📈 Long termA Main Board listing expands eligibility for institutional mandates, reduces liquidity discounts, and enhances corporate visibility as the company executes its ₹527 Cr order book.
⚠ Risk flags
- Subject to shareholder approval by special resolution
- Subject to NSE meeting of eligibility criteria and formal exchange clearance
Key Highlights
Board approved migration from NSE Emerge SME platform to NSE Main Board on October 13, 2026
Shareholder approval to be sought via Special Resolution through remote e-voting postal ballot
M/s. BP & Associates appointed as Scrutinizer for conducting the e-voting process
CDSL engaged to provide the remote e-voting facility to shareholders
👀 What to Watch
Track the outcome of the postal ballot e-voting and subsequent approval timelines from the National Stock Exchange for the listing date on the Main Board.
Texmo Pipes Allots 15.30 Lakh Shares to Promoters for ₹6.98 Cr via Preferential Issue
Texmo Pipes and Products Limited has approved the preferential allotment of 15,30,000 equity shares of face value ₹10 each at an issue price of ₹45.65 per share (including a premium of ₹35.65). The total capital raised amounts to ₹6.98 crore from promoters Shri Sanjay Kumar Agrawal and Smt. Rashmi Agrawal. Consequent to this allotment, the company's total paid-up equity share capital increases from ₹29.20 crore to ₹30.73 crore. Combined holding of these two promoters increased from 34.76% to 38.01%.
Confidence: HIGH
What changedPaid-up equity share capital expanded by 15.3 lakh shares (5.24% dilution) following equity allotment to promoters.
Why it mattersThe ₹6.98 crore equity infusion accounts for ~4.8% of market cap and signals promoter financial commitment to support business operations.
Total fundraise value: Rs. 6,98,44,500Issue price per share: Rs. 45.65Shares allotted: 15,30,000Pre-allotment paid-up capital: Rs. 29,19,50,000Post-allotment paid-up capital: Rs. 30,72,50,000Fundraise vs Market Cap: ~4.8%
📅 Short termPositive sentiment from increased promoter stake, though equity base expands by ~5.24% at a slight discount to current market price.
📈 Long termStrengthens equity net worth slightly and lowers balance sheet leverage, reinforcing promoter skin-in-the-game.
⚠ Risk flags
- Minor equity dilution of 5.24% for existing non-promoter public shareholders
Key Highlights
Allotment of 15,30,000 equity shares at ₹45.65 per share
Total capital raised aggregates to ₹6,98,44,500 (approx. ₹6.98 crore)
Issue price of ₹45.65 represents an ~10.3% discount to the recent market price of ₹50.9
Shri Sanjay Kumar Agrawal's stake increases from 18.66% to 19.46%
Smt. Rashmi Agrawal's stake increases from 16.10% to 18.55%
👀 What to Watch
Track the deployment of the ₹6.98 crore capital infusion and monitor subsequent quarterly shareholding patterns to verify final promoter holding increases.
Texmo Pipes Allots 15.30 Lakh Shares to Promoters for ₹6.98 Cr via Preferential Issue
Texmo Pipes and Products Limited has approved the preferential allotment of 15,30,000 equity shares of face value ₹10 each at an issue price of ₹45.65 per share (including a premium of ₹35.65). The total capital raised amounts to ₹6.98 crore from promoters Shri Sanjay Kumar Agrawal and Smt. Rashmi Agrawal. Consequent to this allotment, the company's total paid-up equity share capital increases from ₹29.20 crore to ₹30.73 crore. Combined holding of these two promoters increased from 34.76% to 38.01%.
Confidence: HIGH
What changedPaid-up equity share capital expanded by 15.3 lakh shares (5.24% dilution) following equity allotment to promoters.
Why it mattersThe ₹6.98 crore equity infusion accounts for ~4.8% of market cap and signals promoter financial commitment to support business operations.
Total fundraise value: Rs. 6,98,44,500Issue price per share: Rs. 45.65Shares allotted: 15,30,000Pre-allotment paid-up capital: Rs. 29,19,50,000Post-allotment paid-up capital: Rs. 30,72,50,000Fundraise vs Market Cap: ~4.8%
📅 Short termPositive sentiment from increased promoter stake, though equity base expands by ~5.24% at a slight discount to current market price.
📈 Long termStrengthens equity net worth slightly and lowers balance sheet leverage, reinforcing promoter skin-in-the-game.
⚠ Risk flags
- Minor equity dilution of 5.24% for existing non-promoter public shareholders
Key Highlights
Allotment of 15,30,000 equity shares at ₹45.65 per share
Total capital raised aggregates to ₹6,98,44,500 (approx. ₹6.98 crore)
Issue price of ₹45.65 represents an ~10.3% discount to the recent market price of ₹50.9
Shri Sanjay Kumar Agrawal's stake increases from 18.66% to 19.46%
Smt. Rashmi Agrawal's stake increases from 16.10% to 18.55%
👀 What to Watch
Track the deployment of the ₹6.98 crore capital infusion and monitor subsequent quarterly shareholding patterns to verify final promoter holding increases.
Talwalkars Sets October 26, 2026 Record Date for Capital Reduction per NCLT Order
Talwalkars Better Value Fitness Limited has fixed October 26, 2026, as the record date for its capital reduction pursuant to an NCLT order. The company reported zero revenue and a net loss of Rs 2.96 crore for the quarter ended June 2026. The capital reduction follows insolvency and restructuring proceedings under NCLT guidelines. Specific share restructuring ratios and post-reduction capital details were not disclosed in the announcement.
Confidence: HIGH
What changedThe company has formally scheduled October 26, 2026, as the cut-off record date to implement its NCLT-mandated capital reduction.
Why it mattersA capital reduction alters the existing equity base and shareholding value, typically wiping out accumulated losses or restructuring equity for insolvent entities.
Record Date: 26.10.2026Quarterly Net Loss (Jun 2026): Rs -2.9568 crQuarterly Revenue (Jun 2026): Rs 0.0 cr
📅 Short termExisting shareholders should expect trading adjustments or temporary suspension of shares around the October 26, 2026 record date.
📈 Long termRestructuring under NCLT could clean up the balance sheet, but long-term viability remains uncertain until business operations and revenues revive.
⚠ Risk flags
- Severe equity dilution or cancellation risk typical of NCLT capital reductions
- Zero operating revenue reported in the latest available quarter
Key Highlights
Record date for capital reduction fixed as October 26, 2026
Capital reduction is being executed pursuant to an NCLT Order under SEBI LODR Regulation 42
Company posted net loss of Rs 2.96 crore on zero revenue in the quarter ended June 2026
Board meeting approving the record date was held on October 13, 2026, from 05:00 PM to 05:30 PM
👀 What to Watch
Track subsequent exchange disclosures detailing the exact swap or reduction ratio of equity shares and trading suspension dates leading up to October 26, 2026.
Talwalkars Reports Q2 Loss of ₹3.03 Cr; Sets Oct 26 Record Date for Share Entitlement
Talwalkars Better Value Fitness reported zero operational revenue and a net loss of ₹303.03 lakhs (₹3.03 crore) for the quarter ended September 30, 2026. The Board approved October 26, 2026, as the record date for determining shareholder entitlement to receive shares pursuant to NCLT and NCLAT orders following its liquidation sale as a going concern. The allotment of 1,00,00,000 new equity shares (95% to acquirers/nominees, 5% to public/strategic investors) remains pending, and trading of the stock on BSE and NSE remains suspended.
Confidence: HIGH
What changedThe Board approved unaudited Q2 results and fixed October 26, 2026, as the record date for share entitlement under the NCLT liquidation resolution framework.
Why it mattersThe company has zero operating revenue, and existing equity shares stood cancelled under the NCLT order, meaning shareholder value hinges entirely on the new share allocation ratio and subsequent listing resumption.
Net Loss (Q2 FY27): ₹303.03 lakhsRevenue from Operations (Q2 FY27): ₹0.00Proposed New Equity Shares: 1,00,00,000Record Date: October 26, 2026Cash and Cash Equivalents: ₹0.55 lakhs
📅 Short termTrading remains suspended; attention will center on the corporate actions around the October 26, 2026 record date and receipt of regulatory approvals.
📈 Long termViability as a going concern depends entirely on successful equity infusion, revival of gym operations, and exchange relisting.
⚠ Risk flags
- Trading suspended on BSE and NSE
- Zero operating revenue and persistent quarterly net losses
- Substantial dilution risk with 95% of new capital earmarked for new promoters/acquirers
- Impairment of fixed assets under Ind AS 36 remains pending
Key Highlights
Revenue from operations was ₹0.00 for Q2 FY27, with total net loss of ₹303.03 lakhs
Record date set for October 26, 2026, to determine existing shareholder entitlement per NCLT order
Allotment of 1,00,00,000 new equity shares pending regulatory approvals (95% to new promoters, 5% to public/strategic)
Depreciation and amortisation expenses stood at ₹269.85 lakhs for the quarter ended September 30, 2026
Cash and cash equivalents reported at ₹0.55 lakhs as of September 30, 2026
👀 What to Watch
Track the outcome of the October 26, 2026 record date and subsequent exchange filings regarding the allotment of new shares and approvals for trading resumption on BSE and NSE.
Tata Elxsi Q2 FY27: Revenue rises 15% YoY to ₹1,055.7 Cr, EBITDA margin at 21.9%
Tata Elxsi reported Q2 FY27 revenue from operations of ₹1,055.7 crore, registering a growth of 3.4% QoQ and 15.0% YoY (2.3% QoQ in constant currency). Operating EBITDA reached ₹231.4 crore with margins expanding 70 bps QoQ to 21.9%, despite absorbing full company-wide salary revisions. Net profit stood flat sequentially at ₹170.3 crore (-0.2% QoQ) but up 10.0% YoY, impacted by lower other income (₹34.9 crore vs ₹41.5 crore in Q1). Growth was broad-based across segments, led by Healthcare (+3.5% CC QoQ), Media & Communications (+3.4% CC QoQ), and Transportation (+2.0% CC QoQ).
Confidence: HIGH
What changedTata Elxsi delivered 15% YoY revenue growth in Q2 FY27 with EBITDA margin expanding to 21.9% after absorbing annual salary increments.
Why it mattersDemonstrates operational resilience and margin defense in a volatile ER&D spending environment, driven by aerospace adjacencies and GenAI deal traction.
Q2 FY27 Revenue from Operations: ₹1,055.7 CrEBITDA Margin: 21.9%PAT: ₹170.3 CrTotal Headcount: 11,149
📅 Short termMargins beating typical wage-hike compression should provide immediate operational comfort, though flat QoQ PAT may cap sentiment.
📈 Long termExpansion into aerospace and defense alongside GenAI integration strengthens domain diversification away from automotive OEM concentration.
⚠ Risk flags
- Sequential decline in employee headcount for multiple quarters
- High client concentration with Top 5 clients contributing 48.9% of revenue
Key Highlights
Revenue from operations grew 3.4% QoQ and 15.0% YoY to ₹1,055.7 crore (2.3% QoQ constant currency)
EBITDA rose 7.1% QoQ to ₹231.4 crore, with EBITDA margin improving by 70 bps QoQ to 21.9%
PAT reported at ₹170.3 crore, up 10.0% YoY but down 0.2% QoQ; basic EPS stood at ₹27.34
Headcount decreased to 11,149 from 11,336 in Q1 FY27, while attrition slightly eased to 15.9%
👀 What to Watch
Track whether headcount stabilizes after consecutive quarters of contraction and observe deal execution velocity across AI and Software Defined Vehicle (SDV) engagements in upcoming quarters.
Tata Elxsi Q2 FY27: Revenue Rises 15.0% YoY to ₹1,055.7 Cr; EBITDA Margin at 21.9%
Tata Elxsi reported Q2 FY27 revenue from operations of ₹1,055.7 crore, up 3.4% QoQ (2.3% in constant currency) and 15.0% YoY. EBITDA grew 7.1% QoQ to ₹231.4 crore, leading to an EBITDA margin of 21.9% (expanding 70 bps QoQ despite company-wide salary revisions). Growth was broad-based, with constant currency growth of 2.0% in Transportation, 3.4% in Media & Communications, and 3.5% in Healthcare & Life Sciences. The company also announced key strategic deal wins across automotive telematics, GenAI assistants, and renal healthcare equipment.
Confidence: HIGH
What changedTata Elxsi reported its Q2 FY27 operational earnings, delivering broad-based constant currency growth across all three core segments alongside margin expansion.
Why it mattersDemonstrates resilient execution with a 70 bps QoQ EBITDA margin expansion despite across-the-board wage hikes, while securing strategic wins in GenAI and connected vehicles.
Operating Revenue: Rs. 1,055.7 CrEBITDA: Rs. 231.4 CrEBITDA Margin: 21.9%YoY Revenue Growth: 15.0%Quarterly Revenue vs TTM Revenue: ~38.9%
📅 Short termThe sequential margin uptick and broad-based vertical growth are likely to provide operational reassurance following recent quarters of automotive sector headwinds.
📈 Long termExpansion into GenAI platforms (including KAVIA AI collaboration) and eVTOL aerospace partnerships position the company well for high-value engineering R&D growth.
⚠ Risk flags
- High vertical dependence on Transportation (>55% of SDS segment)
- Macro slowdown risks in global automotive OEM R&D spending
Key Highlights
Revenue from operations reached ₹1,055.7 Cr, growing 3.4% QoQ and 15.0% YoY (2.3% QoQ constant currency)
EBITDA stood at ₹231.4 Cr, up 7.1% QoQ, with an EBITDA margin of 21.9% (up 70 bps QoQ)
Healthcare & Life Sciences vertical grew 3.5% QoQ cc; Media & Communications grew 3.4% QoQ cc
Transportation vertical grew 2.0% QoQ cc and accounts for over 55% of the SDS segment
👀 What to Watch
Track the margin trajectory in H2 FY27 and deal ramp-ups in the Transportation vertical, particularly regarding client concentration and automotive OEM R&D spending trends.
CRISIL & ICRA Assign 'AAA/Stable' to Sun Pharma's Rs 15,000 Cr NCD Program for Organon Deal
CRISIL and ICRA have assigned 'CRISIL AAA/Stable' and '[ICRA]AAA (Stable)' ratings to Sun Pharma's proposed Rs 15,000 crore Non-Convertible Debenture (NCD) program, while reaffirming existing AAA/A1+ ratings. The credit rating factors in Sun Pharma's proposed $11.75 billion acquisition of US-based Organon & Co. announced in April 2026. Sun Pharma plans to fund the deal via $2.0-2.5 billion in internal cash and $9.5-10.0 billion in additional debt, driving Net Debt to EBITDA to 1.5-2.0x in FY28 before rapid deleveraging.
Confidence: HIGH
What changedRating agencies assigned top-tier 'AAA/Stable' rating to a fresh Rs 15,000 crore NCD program and explicitly incorporated the $11.75 billion Organon acquisition into debt risk assessments.
Why it mattersSecuring the highest domestic rating (AAA) validates Sun Pharma's balance sheet strength and allows it to raise low-cost debt to finance its transformational global acquisition without a credit downgrade.
Proposed NCD Program: Rs 15000 CroreOrganon Deal Enterprise Value: $11.75 billionExpected Incremental Debt: $9.5-10.0 billionNCD Size vs TTM Revenue: ~25.0%Cash Surplus (March 31, 2026): over Rs 30,000 crore
📅 Short termLowers borrowing costs and validates execution readiness for the market as Sun Pharma launches its debt raising for the global acquisition.
📈 Long termPositions Sun Pharma among the top 25 global pharma players ($12.4B combined sales); leverage will temporarily spike to 1.5-2.0x Net Debt/EBITDA but should normalize via strong free cash flow.
⚠ Risk flags
- Substantial leverage increase with $9.5-10.0 billion incremental debt
- Integration challenges of large global footprint across Organon operations
- US regulatory policy risks including drug pricing and tariffs
Key Highlights
Crisil AAA/Stable assigned to proposed Rs 15,000 crore Non-Convertible Debentures (NCDs)
Ratings factor in the mega $11.75 billion acquisition of Organon & Co., expanding pro-forma sales to ~$12.4 billion
Acquisition to be funded by $2.0-2.5 billion internal cash surplus and $9.5-10.0 billion incremental debt
Q1 FY27 operating income rose ~10% YoY to Rs 15,300 crore with operating profit of Rs 4,418 crore
Net Debt to EBITDA expected to peak at 1.5-2.0x in FY28 followed by strong organic deleveraging
👀 What to Watch
Track the timeline of regulatory approvals and closure of the Organon acquisition targeted for late 2026/early 2027, along with debt issuance costs on the proposed NCDs.
Tata Elxsi Reports H1 FY27 Net Profit of ₹340.9 Cr; Cash Flow from Operations Up 40.7%
Tata Elxsi has announced its audited financial results for the quarter and half-year ended September 30, 2026. For the six-month period, net profit reached ₹340.90 Cr, up 13.9% from ₹299.19 Cr in the corresponding period of the previous year. Operating cash flow improved significantly to ₹373.85 Cr compared to ₹265.79 Cr in H1 FY26. The statutory auditors issued an unmodified audit opinion on the interim results.
Confidence: HIGH
What changedTata Elxsi declared its Q2 and H1 FY27 audited financial results with an unmodified audit report.
Why it mattersDemonstrates solid cash conversion and 13.9% year-on-year profit expansion over H1, providing balance sheet resilience despite global ER&D client spending headwinds.
H1 Net Profit: ₹34,089.79 lakhsH1 Cash Flow from Operations: ₹37,385.31 lakhsH1 Dividend Paid: ₹46,722.80 lakhsCash and Cash Equivalents (end of period): ₹16,202.84 lakhs
📅 Short termMarket focus will shift to vertical-level growth breakdown, automotive recovery, and management commentary in the earnings call.
📈 Long termStructural tailwinds in Software Defined Vehicles (SDV) and EV engineering remain intact, supported by strong operating cash generation.
⚠ Risk flags
- Client concentration in the transportation vertical (OEM R&D spending slowdown)
- Talent attrition and offshore pricing pressures
Key Highlights
H1 FY27 profit for the period stood at ₹34,089.79 lakhs (₹340.9 Cr) vs ₹29,918.68 lakhs in H1 FY26
Net cash generated from operating activities rose to ₹37,385.31 lakhs (₹373.85 Cr) from ₹26,578.89 lakhs YoY
Dividend paid in H1 FY27 amounted to ₹46,722.80 lakhs (₹467.23 Cr)
Closing cash and cash equivalents stood at ₹16,202.84 lakhs as of September 30, 2026
Previous year included an exceptional labour code provision of ₹9,568.88 lakhs
👀 What to Watch
Track the full quarterly revenue and margin print along with management commentary on transportation vertical recovery and OEM R&D spending trends.
ARSSBL Reports Q2 FY27 PAT Up 50.3% YoY to ₹41.9 Cr, Revenue Grows 20.3%
Anand Rathi Share and Stock Brokers Limited published its Q2 & H1 FY27 investor presentation, reporting consolidated Q2 FY27 revenue from operations of ₹273.21 Cr, an increase of 20.3% YoY. Net profit (PAT) for the quarter rose 50.3% YoY to ₹41.94 Cr, while EBITDA margin compressed by 423 bps YoY to 36.5%. The Margin Trading Facility (MTF) book expanded 38.2% YoY to ₹1,499.29 Cr, and Assets under Management (AUM) reached ₹9,998.99 Cr, up 29.2% YoY.
Confidence: HIGH
What changedARSSBL submitted its Q2 and H1 FY27 investor presentation, disclosing detailed financial results, operating metrics, and balance sheet data.
Why it mattersDemonstrates robust revenue and profit expansion driven by non-broking activities and MTF scaling, although operating EBITDA margin witnessed compression to 36.5%.
Q2 FY27 Revenue: ₹273.21 CrQ2 FY27 PAT: ₹41.94 CrMTF Book: ₹1,499.29 CrAUM: ₹9,998.99 CrDebt to Equity Ratio: 1.02
📅 Short termThe strong 50.3% YoY growth in quarterly PAT is likely to be viewed favourably by the market in the near term.
📈 Long termDiversification into distribution and MTF helps de-risk pure broking volatility, though heightened regulatory scrutiny on derivatives and cost-to-income discipline remain structural monitorables.
⚠ Risk flags
- EBITDA margin compression of 423 bps YoY in Q2 FY27
- Elevated D/E ratio of 1.02 primarily driven by MTF funding requirements
- Exceptional item of ₹21.0 Cr impacting H1 FY27 profitability
Key Highlights
Q2 FY27 revenue from operations rose 20.3% YoY to ₹273.21 Cr (₹2,732.1 Mn)
Q2 FY27 PAT jumped 50.3% YoY to ₹41.94 Cr (₹419.4 Mn) with PAT margin expanding 313 bps to 15.3%
MTF book increased 38.2% YoY to ₹1,499.29 Cr across 9,191 clients
Assets under Management (AUM) grew 29.2% YoY to ₹9,998.99 Cr; Assets under Custody (AUC) rose 13.2% YoY to ₹1,15,419 Cr
H1 FY27 revenue reached ₹519.32 Cr with PAT after exceptional items of ₹65.29 Cr (up 28.7% YoY)
👀 What to Watch
Track the impact of upcoming SEBI F&O regulatory changes on retail trading volumes and observe whether MTF book growth sustains without increasing credit risk.
Sejal Glass Q2 FY27 Consolidated Net Profit Up; Foreign Unit Posts ₹13.65 Cr PAT
Sejal Glass announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. For H1 FY27, consolidated profit before tax reached ₹23.67 crore compared to ₹12.53 crore in H1 FY26, driven significantly by its foreign subsidiary (Sejal Glass & Glass Manufacturing Products LLC), which recorded revenue of ₹97.03 crore and net profit of ₹13.65 crore for Q2. Consolidated net cash flow from operating activities stood at ₹34.88 crore for the half-year versus ₹42.28 crore in the prior period. Net cash and cash equivalents grew to ₹23.32 crore as of September 30, 2026.
Confidence: HIGH
What changedSejal Glass reported its Q2 and H1 FY27 financial performance along with limited review reports from auditors.
Why it mattersDemonstrates sustained operational contributions and healthy profitability from its foreign subsidiary despite elevated regional exposure.
Consolidated PBT (H1 FY27): ₹2,367.39 lakhsForeign Subsidiary Q2 Revenue: ₹9,702.95 lakhsForeign Subsidiary Q2 PAT: ₹1,365.24 lakhsConsolidated Operating Cash Flow (H1): ₹3,488.45 lakhsConsolidated Capex (H1): ₹2,267.84 lakhs
📅 Short termMarkets will review the steady operational results and improved cash position from international operations.
📈 Long termLong-term execution relies on maintaining margin performance in value-added architectural glass and mitigating Middle East regional risks.
⚠ Risk flags
- High dependence on UAE foreign subsidiary for consolidated revenues and profit
- Standalone operating cash flow for H1 remained negative at ₹(8.80) crore
Key Highlights
H1 FY27 consolidated Profit Before Tax rose to ₹23.67 crore from ₹12.53 crore in H1 FY26
Foreign subsidiary contributed Q2 revenue of ₹97.03 crore and net PAT of ₹13.65 crore
H1 FY27 capex on fixed assets reached ₹22.68 crore consolidated, down from ₹51.18 crore in H1 FY26
Consolidated cash flow from operating activities closed at ₹34.88 crore for the half-year
Total cash and cash equivalents improved to ₹23.32 crore at end of period compared to ₹5.35 crore previously
👀 What to Watch
Track subsequent quarterly profitability and monitor geographic concentration in the UAE subsidiary, which contributes the majority of operational profits.
Sejal Glass Q2 FY27 Consolidated Net Profit Up; Foreign Unit Posts ₹13.65 Cr PAT
Sejal Glass announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. For H1 FY27, consolidated profit before tax reached ₹23.67 crore compared to ₹12.53 crore in H1 FY26, driven significantly by its foreign subsidiary (Sejal Glass & Glass Manufacturing Products LLC), which recorded revenue of ₹97.03 crore and net profit of ₹13.65 crore for Q2. Consolidated net cash flow from operating activities stood at ₹34.88 crore for the half-year versus ₹42.28 crore in the prior period. Net cash and cash equivalents grew to ₹23.32 crore as of September 30, 2026.
Confidence: HIGH
What changedSejal Glass reported its Q2 and H1 FY27 financial performance along with limited review reports from auditors.
Why it mattersDemonstrates sustained operational contributions and healthy profitability from its foreign subsidiary despite elevated regional exposure.
Consolidated PBT (H1 FY27): ₹2,367.39 lakhsForeign Subsidiary Q2 Revenue: ₹9,702.95 lakhsForeign Subsidiary Q2 PAT: ₹1,365.24 lakhsConsolidated Operating Cash Flow (H1): ₹3,488.45 lakhsConsolidated Capex (H1): ₹2,267.84 lakhs
📅 Short termMarkets will review the steady operational results and improved cash position from international operations.
📈 Long termLong-term execution relies on maintaining margin performance in value-added architectural glass and mitigating Middle East regional risks.
⚠ Risk flags
- High dependence on UAE foreign subsidiary for consolidated revenues and profit
- Standalone operating cash flow for H1 remained negative at ₹(8.80) crore
Key Highlights
H1 FY27 consolidated Profit Before Tax rose to ₹23.67 crore from ₹12.53 crore in H1 FY26
Foreign subsidiary contributed Q2 revenue of ₹97.03 crore and net PAT of ₹13.65 crore
H1 FY27 capex on fixed assets reached ₹22.68 crore consolidated, down from ₹51.18 crore in H1 FY26
Consolidated cash flow from operating activities closed at ₹34.88 crore for the half-year
Total cash and cash equivalents improved to ₹23.32 crore at end of period compared to ₹5.35 crore previously
👀 What to Watch
Track subsequent quarterly profitability and monitor geographic concentration in the UAE subsidiary, which contributes the majority of operational profits.
Glass Wall Systems Targets 20-25% Revenue CAGR, 23-25% EBITDA Margins in Maiden Concall
Glass Wall Systems held its inaugural earnings conference call for Q1 FY27 post-listing, guiding for 20% to 25% top-line revenue CAGR alongside 23% to 25% EBITDA and 18% to 20% PAT margin expectations. The company reported domestic market share of 6% to 7% and holds the second-largest position among organized facade solution providers in India. Additionally, the in-house Glass Processing Unit (GPU) is slated for commissioning in ~8 months, which management expects will add 100-150 bps to the bottom line.
Confidence: HIGH
What changedFiling of the maiden Q1 FY27 earnings conference call transcript, providing quantitative margin and revenue growth guidance post-IPO.
Why it mattersGives clear management visibility on order pipeline, margins (23-25% EBITDA), and backward-integration margin accretion from the new glass processing unit.
Expected Revenue CAGR: 20%-25%Target EBITDA Margin: 23%-25%Target PAT Margin: 18% to 20%Domestic Market Share: 6% to 7%GPU Commissioning Timeline: around 8 monthsGPU Bottom-Line Impact: around 1%, 1.5%
📅 Short termProvides operational clarity and confirms stable performance following recent listing; market is likely to view margin guidance positively.
📈 Long termBackward integration into glass processing combined with international facade supplies (US exports) could support guided 20-25% growth and healthy returns.
⚠ Risk flags
- Project execution cycles (18-24 months) sensitive to real estate construction delays
- US export concentration risk in the international segment
Key Highlights
Targets long-term revenue CAGR of 20% to 25% while maintaining a 2-year forward order book visibility
Guides for steady-state margins of 23% to 25% EBITDA and 18% to 20% PAT
In-house Glass Processing Unit (GPU) commissioning targeted within ~8 months, expected to expand bottom-line margin by 1% to 1.5%
Domestic market share stands at 6% to 7%, ranking as the second-largest facade player in India
👀 What to Watch
Track the 8-month commissioning timeline of the new GPU facility and verify whether quarterly revenue growth sustains at the guided 20-25% run rate.
ARSSBL Q2 FY27 Net Profit Jumps 50% YoY to ₹41.9 Cr, Revenue Up 20% to ₹273.2 Cr
Anand Rathi Share and Stock Brokers reported a 20% YoY increase in consolidated revenue from operations to ₹273.2 crore (₹2,732 million) for Q2 FY27. Profit after tax (PAT) rose 50.3% YoY to ₹41.9 crore (₹419 million), with PAT margins reaching 15%. Growth was supported by non-broking streams, with the MTF book expanding 38.2% YoY to ₹1,499.3 crore (₹14,993 million) and generating ₹49.6 crore in interest income. For H1 FY27, revenue reached ₹519.3 crore with PAT before exceptional items at ₹81.0 crore.
Confidence: HIGH
What changedARSSBL released strong Q2 FY27 earnings showing accelerated non-broking and MTF growth, alongside 50% YoY profit expansion.
Why it mattersDemonstrates successful diversification away from pure broking into higher-margin MTF and distribution assets, strengthening revenue stability and profitability.
Q2 FY27 Revenue: ₹2,732 millionQ2 FY27 PAT: ₹419 millionMTF Book size: ₹14,993 millionH1 FY27 PAT before exceptional items: ₹810 millionQ2 Revenue vs TTM Revenue: ~28.0%
📅 Short termEarnings outperformance and substantial PAT margin improvement are likely to be viewed favourably by the market in the immediate trading sessions.
📈 Long termExpanding recurring distribution and MTF books help mitigate cyclical retail trading downturns, supporting stable compounding if operational costs stay managed.
⚠ Risk flags
- SEBI derivative regulation tightening (higher contract sizes/expiry changes) could hurt broking volumes
- Elevated cost-to-income structure and dependence on parent entity ARFSL
Key Highlights
Q2 FY27 Revenue from Operations grew 20.3% YoY to ₹2,732 million (₹273.2 crore)
Q2 FY27 PAT rose 50.3% YoY to ₹419 million with an EBITDA margin of 37%
MTF book increased 38.2% YoY to ₹14,993 million, generating interest income of ₹496 million (up 36.3% YoY)
Assets under Management (AUM) grew 29.2% YoY to ₹99,990 million, while AUC reached ₹11,54,190 million
Trail-based recurring revenues expanded to cover 76% of employee costs
👀 What to Watch
Track the impact of upcoming SEBI regulatory shifts on F&O trading volumes and evaluate whether MTF growth can sustain margins despite broader market volatility.
ARSSBL Q2 Standalone PAT Rises 48% YoY to ₹42.3 Cr; Revenue Up 20% to ₹272.7 Cr
Anand Rathi Share and Stock Brokers reported standalone revenue from operations of ₹272.74 Cr for Q2 FY27 (ended September 30, 2026), marking a 20.1% increase compared to ₹227.09 Cr in Q2 FY26. Standalone net profit rose 48% YoY to ₹42.30 Cr from ₹28.59 Cr in the year-ago period, driven by growth in fees and interest income. For H1 FY27, revenue reached ₹518.42 Cr while PAT stood at ₹65.81 Cr despite an exceptional charge of ₹20.99 Cr recognized in Q1. The Debt-to-Equity ratio stood at 1.02 as of September 30, 2026.
Confidence: HIGH
What changedARSSBL reported its Q2 and H1 FY27 results, showing strong operational revenue and profit rebound post the Q1 exceptional hit.
Why it mattersDemonstrates robust core operational resilience with expanding broking and lending revenues, though leverage increased and fraud recovery remains pending.
Q2 Standalone Revenue: ₹272.74 CrQ2 Standalone PAT: ₹42.30 CrQ2 Basic EPS: ₹6.71H1 Exceptional Item: ₹20.99 CrDebt-Equity Ratio: 1.02
📅 Short termMarket may view the 48% YoY profit jump favorably, offsetting past concern over the Q1 exceptional loss.
📈 Long termGrowth in interest and fee income supports structural scaling, though upcoming SEBI F&O norms and elevated cost structures remain long-term monitoring points.
⚠ Risk flags
- Pending final resolution and insurance recovery on the ₹20.99 Cr fraud investigation by EOW
- Rising leverage with debt-equity increasing to 1.02 from 0.62 in March 2026
Key Highlights
Standalone Q2 revenue from operations grew 20.1% YoY to ₹272.74 Cr from ₹227.09 Cr.
Standalone Q2 PAT rose 47.9% YoY to ₹42.30 Cr compared to ₹28.59 Cr in Q2 FY26.
Fees and commission income for Q2 stood at ₹166.86 Cr, up from ₹129.67 Cr in the prior-year period.
H1 standalone PAT reached ₹65.81 Cr after factoring in an exceptional loss of ₹20.99 Cr incurred in Q1 related to fraudulent transactions under EOW investigation.
Debt-to-equity ratio rose to 1.02 as of September 30, 2026, compared to 0.62 as of March 31, 2026.
👀 What to Watch
Track subsequent disclosures on insurance claim recoveries or legal asset realizations related to the ₹20.99 Cr exceptional loss, and monitor debt levels as leverage expanded to 1.02x.
